ODT
Income statement / Annual
Last year (2020), Odonate Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Odonate Therapeutics, Inc.'s net income was -$126.35 M.
See Odonate Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$117.04 M
|
$104.03 M
|
$79.95 M
|
$27.90 M
|
$2.62 M
|
$0.00
|
General & Administrative Expenses |
$10.39 M
|
$10.90 M
|
$10.82 M
|
$4.84 M
|
$463,000.00
|
$158,000.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$10.39 M
|
$10.90 M
|
$10.82 M
|
$4.84 M
|
$463,000.00
|
$158,000.00
|
Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$316,000.00
|
Operating Expenses |
$127.43 M
|
$114.93 M
|
$90.76 M
|
$32.74 M
|
$3.09 M
|
-$158,000.00
|
Cost And Expenses |
$127.43 M
|
$114.93 M
|
$90.76 M
|
$32.74 M
|
$3.09 M
|
$158,000.00
|
Interest Income |
$0.00
|
$3.11 M
|
$1.80 M
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$445,000.00
|
$381,000.00
|
$350,000.00
|
$20,000.00
|
$22,816.00
|
$0.00
|
EBITDA |
-$125.91 M |
-$111.44 M |
-$88.61 M |
-$32.72 M |
-$3.09 M |
-$158,000.00 |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$1.08 M
|
$3.11 M
|
$1.80 M
|
$0.00
|
$0.00
|
$0.00
|
Income Before Tax |
-$126.35 M
|
-$111.83 M
|
-$88.96 M
|
-$32.74 M
|
-$3.09 M
|
-$158,000.00
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$1.08 M
|
$3.11 M
|
$1.80 M
|
$0.00
|
$0.00
|
$0.00
|
Net Income |
-$126.35 M
|
-$111.83 M
|
-$88.96 M
|
-$32.74 M
|
-$3.09 M
|
-$158,000.00
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
EPS |
-3.85 |
-4.05 |
-3.64 |
-2.31 |
-0.11 |
-0.0059 |
EPS Diluted |
-3.85 |
-4.05 |
-3.64 |
-2.31 |
-0.11 |
-0.0059 |
Weighted Average Shares Out |
$32.82 M
|
$27.63 M
|
$24.46 M
|
$14.17 M
|
$26.89 M
|
$26.89 M
|
Weighted Average Shares Out Diluted |
$32.82 M
|
$27.63 M
|
$24.46 M
|
$14.17 M
|
$26.89 M
|
$26.89 M
|
Link |
|
|
|
|
|
|